Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive Analysis of CPA4 as a Poor Prognostic Biomarker Correlated with Immune Cells Infiltration in Bladder Cancer

6 Nov 2021

Abstract excerpt

Carboxypeptidase A4 (CPA4) has shown the potential to be a biomarker in the early diagnosis of certain cancers. However, no previous research has linked CPA4 to therapeutic or prognostic significance in bladder cancer. Using data from The Cancer Genome Atlas (TCGA) database, we set out to determine the full extent of the link between CPA4 and BLCA. We further analyzed the interacting proteins of CPA4 and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Ferroptosis and cancer prognosis
Share to Peptidase Inhibition and Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34827136
DOI: 10.3390/biology10111143

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive Analysis of CPA4 as a Poor Prognostic Biomarker Correlated with Immune Cells Infiltration in Bladder CancerPMID 34827136Read ↗

Comprehensive Analysis of CPA4 as a Poor Prognostic Biomarker Correlated with Immune Cells Infiltration in Bladder CancerSemantic proximity Read ↗

Identification of Four Immune Subtypes in Bladder Cancer Based on Immune Gene SetsSemantic proximity Read ↗

Identification of tumor antigens and immune subtypes of bladder cancer for mRNA vaccine developmentSemantic proximity Read ↗

Proteomic and In Silico Analyses Highlight Complement System’s Role in Bladder Cancer Immune RegulationSemantic proximity Read ↗

Comprehensive Analysis of Clinical Prognosis and Molecular Immune Characterization of TPM4 in Pancreatic CancerSemantic proximity Read ↗

Identification and validation of immune and diagnostic biomarkers for interstitial cystitis/painful bladder syndrome by integrating bioinformatics and machine-learningSemantic proximity Read ↗

Exploring prognostic DNA methylation genes in bladder cancer: a comprehensive analysisSemantic proximity Read ↗

GATA3 Predicts the Tumor Microenvironment Phenotypes and Molecular Subtypes for Bladder CarcinomaSemantic proximity Read ↗

PSMD2 promotes the progression of bladder cancer and is correlated with immune infiltrationSemantic proximity Read ↗

Prognostic implications of a four-gene signature in non-muscle invasive bladder cancerSemantic proximity Read ↗

Tertiary lymphoid structure patterns aid in identification of tumor microenvironment infiltration and selection of therapeutic agents in bladder cancerSemantic proximity Read ↗

Upregulation of CHAC1 promotes bladder inflammation and predicts adverse prognosis in Bladder Urothelial CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.